2016
DOI: 10.1016/j.ejso.2016.02.188
|View full text |Cite
|
Sign up to set email alerts
|

Neoadjuvant chemotherapy versus neoadjuvant endocrine therapy in postmenopausal women with ER+ Her2- breast cancer and axillary involvement

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles